Using health economic models to help guide healthcare decisions

Abstract

This editorial accompanies a research article being published by Clinical Medical Research and Opinion (CMRO) journal, entitled "Methods applied in cost-effectiveness models for treatment strategies in type 2 diabetes mellitus and their use in Health Technology Assessments: a systematic review of the literature from 2008 to 2013". The importance and the contribution of this research to the scientific community are presented on the grounds of serving the decision-making process of evaluating and approving T2DM treatments for public funding.

Keywords: :

• Diabetes
• Health economics
• Model
• Qualitative assessment
• Systematic literature review

Transparency

Declaration of funding

This editorial was not funded.

Declaration of financial/other relationships

M.C. has disclosed that she was an employee of Pharmerit International at the time of the research.

Acknowledgments

The author has disclosed that she had no outside editorial assistance in preparing this editorial. The author thanks the editors of CMRO and Bram G. Verheggen (Director HEOR, Pharmerit International) for their valuable comments.